Patients can be also classified according to response to treatment as refractory when ... who met the classification criteria for the diagnosis of JDM [15 15 Bohan A, Peter JB. Polymyositis and ...

Methods: Patients with inflammatory myositis of recent onset who had not received treatment were evaluated for ... Two patients with polymyositis had cardiac clinical symptoms. Two other patients with ...

Idiopathic inflammatory myopathies (IIM) include a heterogenous group of rare disorders including dermatomyositis ... biomarkers for early diagnosis complicates disease management and underscores the ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Patients who are evaluated through the ADMDC should expect to have their options for treatment identified and explained to them so that they may make a well informed decision about their care. If a ...

Though it’s the most common skin condition in the United States, determining the best acne treatment for your skin is still challenging. Acne treatments include prescription medications ...

A strict life-long gluten-free diet is the only safe and efficient available treatment, yet it results in a social burden. Alternative treatment modalities focus on modification of dietary ...

A focused history and systematic physical assessment provide a step-by-step guide to enhance the early recognition of clinical signs and symptoms of this disorder. A series of clinical photographs ...

Nov. 8, 2024 — Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research ... Two Key Genes Identified ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2024, along with recent product highlights and corporate ...